Previous studies have demonstrated the efficacy of 3D-printed bioactive ceramic (3DBC) scaffolds in the restoration of long bone defects. The objective of this study is to test the efficacy of the osteogenic agent dipyridamole on 3DBC scaffold-mediated healing of calvarial defects using a sheep model.
PURPOSE:
Previous studies have demonstrated the efficacy of 3D-printed bioactive ceramic (3DBC) scaffolds in the restoration of long bone defects. The objective of this study is to test the efficacy of the osteogenic agent dipyridamole on 3DBC scaffold-mediated healing of calvarial defects using a sheep model.
METHODS:
Custom 3DBC scaffolds were either coated with collagen (control) or coated with collagen and immersed in 100 μM dipyridamole (DIPY). Sheep (n=5) were subjected to 4 trephine-induced (12 mm diameter) calvarial defects with immediate scaffold placement via two separate operations: anteriorly (control) and posteriorly (DIPY) on the right (3 weeks healing) and left (6 weeks healing) sides of the calvarium. Following sacrifice, defects were evaluated through microcomputed tomography and histologic analysis for bone, scaffold, and soft tissue quantification as a function of time in vivo. Statistical analysis was performed by a mixed model and significance was defined by p<0.05.
RESULTS:
Histologic evaluation demonstrated no signs of inflammation within the defects. Significantly higher percentage of bone formation (p=0.02) was observed for the DIPY-containing scaffolds. A significant increase in bone percentage was observed from 3 to 6 weeks in vivo irrespective of scaffold group (p<0.01). Differences between groups were more pronounced at 6 weeks in vivo (~90% more for DIPY). No exuberant or ectopic bone formation was observed in either experimental group.
CONCLUSION:
Defects treated with dipyridamolecontaining 3DBC scaffolds demonstrated significantly improved bone generation without histologic evidence of inflammation or ectopic bone formation. 
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PURPOSE:
The accessibility of adipose-derived stromal cells (ASCs) over bone marrow stromal cells (BMSCs) warrants investigation into their utility for bone healing. The goal of this study was to compare the mechanisms through which ASCs and BMSCs exert their effect on fracture healing. We hypothesize that ASCs will enhance fracture healing by improving vasculogenesis, while BSMCs will directly affect osteogenesis.
METHODS:
Lewis rats were radiated (35Gy) and underwent mandibular osteotomy with implantation of BMSCs (n=12) or ASCs (n=16) marked with Green fluorescent protein (GFP). MicroCT and Confocal microscopy evaluated 40-day union rates and the contribution of ASCs/ BMSCs to the bone regenerate. Quantitative PCR of ASCs/BMSCs compared expression of osteogenic and vasculogenic genes. Co-culture of ASCs (n=3) or BMSCs (n=3) with human umbilical vein endothelial cells (HUVECs) was performed to measure tubule formation/ vasculogenesis.
RESULTS:
ASC-implantation resulted in higher union rates than BMSC-implantation (94% vs. 66%), and contributed indirectly to fracture healing, as GFP was not visualized. (Fig. 1A ) BMSCs expressed osteogenic genes to a significantly greater degree than did ASCs. (1B) ASCs expressed greater levels of VEGF, translating into greater tubule formation among co-cultured HUVECs (64.3 ± 7.3 vs. 23.3 ± 2.6; p=0.0008). (1C) CONCLUSION: ASCs heal fractures better than BMSCs, likely through indirect modulation of vasculogenesis, rather than osteogenesis. ASCs may be a promising clinical option for radiation-induced fracture repair, given their accessibility and improved fracture healing.
